Fluctuating levels of anti-GBM antibodies following a fungal infection in a patient with secondary amyloidosis.
Tsagalis
G C
GC
Margelos
V
V
Nikolopoulou
N
N
Hadjiconstantinou
V E
VE
D000666:Amphotericin B / Q000627:therapeutic use; D000686:Amyloidosis / Q000276:immunology*; D019867:Anti-Glomerular Basement Membrane Disease / Q000276:immunology; D000906:Antibodies / Q000097:blood*; D000974:Antibodies, Antinuclear / Q000097:blood; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000276:immunology*; D001323:Autoantibodies; D005260:Female; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000276:immunology*; D008875:Middle Aged
D000906:Antibodies; D000974:Antibodies, Antinuclear; D000935:Antifungal Agents; D001323:Autoantibodies; C051951:antiglomerular basement membrane antibody; D000666:Amphotericin B